CJC-1295 vs Sermorelin: A Comparative Analysis of GHRH Analogues
A detailed comparison of two growth hormone-releasing hormone (GHRH) analogues. We examine their structural differences, pharmacokinetic profiles, and research applications in somatotroph stimulation studies.
Introduction
CJC-1295 and Sermorelin are both synthetic analogues of growth hormone-releasing hormone (GHRH), the endogenous peptide that stimulates the anterior pituitary to secrete growth hormone (GH). Despite sharing a common mechanism of action — agonism at the GHRH receptor — their structural modifications result in significantly different pharmacokinetic profiles.
Structural Comparison
Sermorelin (GHRH 1-29)
- CAS: 86168-78-7
- Molecular Formula: C152H252N44O42
- Molecular Weight: ~3367.9 g/mol
- Structure: Full-length N-terminal 1-29 fragment of GHRH
Sermorelin represents the biologically active portion of the 44-amino acid GHRH molecule. It retains the full biological activity of the native hormone but is susceptible to rapid enzymatic degradation by dipeptidyl peptidase IV (DPP-IV).
CJC-1295 with DAC
- CAS: 446262-90-4
- Molecular Formula: C165H269N47O46
- Molecular Weight: ~3647.25 g/mol
- Structure: Modified GHRH(1-29) with Drug Affinity Complex (DAC)
CJC-1295 DAC incorporates a lysine residue that enables covalent binding to serum albumin, extending the half-life from minutes to several days. This modification dramatically increases its duration of action compared to both Sermorelin and CJC-1295 without DAC.
CJC-1295 without DAC (Modified GRF 1-29)
- CAS: 863288-34-0
- Molecular Weight: ~3367.9 g/mol
- Structure: DPP-IV-resistant GHRH(1-29) analogue
This variant incorporates amino acid substitutions at positions 2, 8, 15, and 27, conferring resistance to DPP-IV cleavage while maintaining physiological pulsatility.
Pharmacokinetic Differences
| Parameter | Sermorelin | CJC-1295 (no DAC) | CJC-1295 DAC |
|---|---|---|---|
| Half-life | ~10-20 minutes | ~30 minutes | 6-8 days |
| DPP-IV sensitive | Yes | No | No |
| Albumin binding | No | No | Yes |
| GH pulsatility | Physiological | Physiological | Extended elevation |
Research Applications
Sermorelin
- Diagnostic use: Growth hormone deficiency testing
- Physiological studies: Investigating natural GH pulsatility patterns
- Paediatric research: Short stature studies in children
CJC-1295 (no DAC)
- Pulsatile GH studies: Mimicking physiological GH release patterns
- Anti-aging research: Investigating age-related GH decline
- Body composition studies: Examining effects on lean body mass
CJC-1295 DAC
- Sustained elevation studies: Investigating the effects of prolonged GH elevation
- Pharmacokinetic modelling: Studying albumin-binding peptide technology
- Comparative research: Contrasting pulsatile vs sustained GH elevation
Which Should Researchers Choose?
The choice between these analogues depends entirely on the research question:
- For physiological pulsatility: Sermorelin or CJC-1295 (no DAC)
- For sustained GH elevation: CJC-1295 with DAC
- For diagnostic purposes: Sermorelin (FDA-approved for GH deficiency testing)
Safety Considerations
All products are sold for research purposes only. Not for human consumption. These compounds should only be used in accredited research facilities following institutional review board approval.
Disclaimer: This article is for informational and educational purposes only. All products are sold for research purposes only.